Outcomes of a multicentre randomised clinical trial of etanercept to treat ankylosing spondylitis
Articolo
Data di Pubblicazione:
2004
Citazione:
Outcomes of a multicentre randomised clinical trial of etanercept to treat ankylosing spondylitis / Calin, A; Dijkmans, B. A. C; Emery, P; Hakala, M; Kalden, J; Leirisalo Repo, M; Mola, E. M; Salvarani, Carlo; Sanmartí, R; Sany, J; Sibilia, J; Sieper, J; Van Der Linden, S; Veys, E; Appel, A. M; Fatenejad, S.. - In: ANNALS OF THE RHEUMATIC DISEASES. - ISSN 0003-4967. - 63:12(2004), pp. 1594-1600. [10.1136/ard.2004.020875]
Abstract:
A double blind, randomised, placebo controlled study to evaluate the safety and efficacy of etanercept to treat adult patients with ankylosing spondylitis (AS).
Tipologia CRIS:
Articolo su rivista
Keywords:
Adult; Antirheumatic Agents; C-Reactive Protein; Double-Blind Method; Female; Humans; Immunoglobulin G; Immunologic Factors; Male; Middle Aged; Receptors, Tumor Necrosis Factor; Severity of Illness Index; Spine; Spondylitis, Ankylosing; Treatment Outcome
Elenco autori:
Calin, A; Dijkmans, B. A. C; Emery, P; Hakala, M; Kalden, J; Leirisalo Repo, M; Mola, E. M; Salvarani, Carlo; Sanmartí, R; Sany, J; Sibilia, J; Sieper, J; Van Der Linden, S; Veys, E; Appel, A. M; Fatenejad, S.
Link alla scheda completa:
Link al Full Text:
Pubblicato in: